Ken Fisher's position in Viridian Therapeutics is currently worth $29.4M. That's 0.01% of their equity portfolio (291st largest holding). The investor owns 1.96% of the outstanding Viridian Therapeutics stock. The first Viridian Therapeutics trade was made in Q1 2024. Since then Ken Fisher bought shares six more times and sold shares on two occasions. The investor's estimated purchase price is $37.5M, resulting in a loss of 22%.